Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07122661) titled 'STudy of Real World vaccinE Effectiveness of maTernal RSVpreF vaccinatiON Against Respiratory Syncytial Virus (RSV) in Hospitalised Infants in Australia (STREETON)' on Aug. 7.
Study Type: Observational
Primary Sponsor: Pfizer
Condition:
Respiratory Syncytial Virus (RSV)
Respiratory Syncytial Virus
Lower Respiratory Tract Disease
Respiratory Tract Diseases
Acute Respiratory Illness (ARI)
Intervention:
Biological: ABRYSVO
Recruitment Status: Not recruiting
Date of First Enrollment: August 11, 2025
Target Sample Size: 1
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07122661
Published by HT Digit...